Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs LYFT Inc (LYFT) Price & Performance

Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs LYFT Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while LYFT Inc trades at $17.52 (market cap $6.64B). The key difference: Quest Diagnostics Inc is far larger — about 3.9× LYFT Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.

DGXLYFT
Market Cap
$26.21B$6.64B
Sector
HealthIndustrials
52-Week High
$238.50$24.57
52-Week Low
$173.49$12.65
Enterprise Value
$31.97B$6.11B
Dividend Yield
1.45%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About LYFT Inc

Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.

Read more on LYFT